This Week on NeurologyLive — July 5, 2021


Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

This week, the NeurologyLive staff is collecting responses for our second quarterly audience survey. The insights derived from this short questionnaire will help our editorial team ensure that you get access to the insight, coverage, and content that is most meaningful to you, delivered in the ways you most prefer. We kindly ask you to share 5 minutes of your time with us in order to help us better understand how you use social media and how we can better serve you across different platforms.

To take the survey, click here.

We've launched a new Peer Exchange series featuring a number of multiple sclerosis (MS) experts, called "Optimal Management of Relapsing Multiple Sclerosis." The experts, including Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD, explore several topics pertaining to the diagnosis and treatment of relapsing MS, including current treatment options, therapy sequencing, and the future of MS management, among a number of other topics. There are new episodes going live this week, and prior ones to catch up on.

To catch up on the series, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, goes live on Wednesday, July 7. This week, our post features a conversation with Yung Chyung, MD, chief medical officer, Scholar Rock, who discussed the phase 2 TOPAZ study of apitegromab in patients with spinal muscular atrophy. Chyung provided thoughts on the data, reasons behind the layered approach with nusinersen, the significant unmet needs for ambulatory and non-ambulatory type 2 and 3 patients, and the design for the subsequent phase 3 trial. He also discussed the drug's mechanism of action and whether a new drug submission would be in its future.

To check out the prior NeuroVoices conversations, click here.

This week the MJH Life Sciences Medical World News streaming channel is airing fresh new episodes of your favorite shows on a daily basis. This week, NeurologyLive will be contributing to an episode of Second Opinion, which will showcase a conversation between Jessica Ailani, MD, director, Headache Center, MedStar Georgetown University Hospital, and Rashmi Halker-Singh, MD, associate professor of neurology, Mayo Clinic, who shared their insight into a number of day-to-day challenges faced by physicians including the scenario in which a patient switches providers, how to deal with a negative review, and the importance of having a support system.

To catch up and check out what's on the Medical World News channel now, click here, or to check out hundreds of episodes on-demand, click here.

The NeurologyLive Peer Exchange series, "Redefining Treatment Outcomes in Dravet Syndrome," is premiering new episodes! The series offers recommendations for the diagnosis, treatment, and management of patients with Dravet syndrome and features insights from experts in the treatment of the rare epilepsy, including Joseph Sullivan, MD; Trevor J. Resnick, MD; Elizabeth A. Thiele MD, PhD; and Elaine C. Wirrell, MD. Thus far, the group has provided an overview of Dravet syndrome and explored why the early diagnosis is vital to care, which patient profiles should be noted for ordering genetic testing, and what to do with those results.

To catch up on the series, click here.

We've launched a new NeurologyLive Peer Exchange series, "Recognizing and Managing Advanced Parkinson Disease," featuring Adolfo Ramirez-Zamora, MD; Joohi Jimenez-Shahed, MD; Aristide Merola, MD, PhD; and Michael J. Soileau, MD, who came together to discuss the diagnosis and treatment of advanced Parkinson disease, including recognition of symptoms, the burden patients experience, and disease progression, among other topics.

To catch up on the series, click here.

The fourth installment of our webinar series, "The Ever-Changing Face of Multiple Sclerosis," put on in partnership with the Consortium of Multiple Sclerosis Centers, is set for Wednesday, July 21, at 7:00 PM ET. This time, the conversation will focus on the evolving rehabilitation strategies for patients with MS, and will feature Ahmed Obeidat, MD, PhD; Nicholas C. Ketchum, MD; Francois Bethoux, MD, who aim to share their insight into gait and ambulation issues, spasticity and its management, the incorporation of technology into rehabilitation, and the traditional versus nontraditional approaches,

To register for the broadcast for free, click here.

If you missed the previous webinar on June 16, 2021, don't worry! It featured a detailed discussion on the evolution of diagnosis and treating multiple sclerosis care during a pandemic featuring Ahmed Obeidat, MD, PhD; Anne Cross, MD; and Gloria von Geldern, MD, and you can now watch it on-demand by registering for free on the site.

To view the enduring version of the first 3 programs, click here for our Future Leaders in Neurology section.

Related Videos
Bruce Cree, MD
A panel of 3 experts on Alzheimer's disease
A panel of 3 experts on Alzheimer's disease
Christos Papadelis, PhD
Ro'ee Gilron, PhD
Monica Verduzco-Gutierrez, MD
Shahid Nimjee, MD, PhD
Peter J. McAllister, MD, FAAN
Video 6 - "Utilization of Neuroimaging in Alzheimer’s Disease"
© 2024 MJH Life Sciences

All rights reserved.